Overview
Universal Health Q3 revenue grows 13.4% yr/yr, beating analyst expectations
Adjusted EPS for Q3 beats analyst expectations, reflecting strong performance
Company increases stock repurchase program by $1.5 bln
Outlook
Universal Health raises 2025 net revenue forecast to $17.306 bln-$17.445 bln
Company increases 2025 adjusted EBITDA forecast to $2.569 bln-$2.619 bln
Universal Health raises 2025 adjusted EPS forecast to $21.50-$22.10
Result Drivers
ACUTE CARE REVENUE - Net revenue per adjusted admission and per adjusted patient day increased significantly, driving revenue growth in acute care services
MEDICAID REIMBURSEMENT - $90 mln pre-tax reimbursements from Medicaid program in Washington, D.C., boosted net income
LIABILITY RESERVES - Increased reserves for self-insured liabilities due to unfavorable claims trends impacted results
Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q3 Revenue
Beat
$4.49 bln
$4.34 bln (14 Analysts)
Q3 Adjusted EPS
Beat
$5.69
$4.79 (16 Analysts)
Q3 EPS
$5.86
Q3 Adjusted Net Income
Beat
$362.30 mln
$308.54 mln (9 Analysts)
Analyst Coverage
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 8 "strong buy" or "buy", 13 "hold" and 1 "sell" or "strong sell"
The average consensus recommendation for the healthcare facilities & services peer group is "buy."
Wall Street's median 12-month price target for Universal Health Services Inc is $221.24, about 4.8% above its October 24 closing price of $210.68
The stock recently traded at 10 times the next 12-month earnings vs. a P/E of 9 three months ago
Press Release: ID:nPn2LSGjxa
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)